tretinoin

FDA Drug Profile — TRETINOIN, Tretinoin, Tretinoin (Microsphere), Tretinoin Cream, Altreno

tretinoin is listed in the FDA National Drug Code directory with 40 NDC codes, marketed under brand names including TRETINOIN, Tretinoin, Tretinoin (Microsphere). Available dosage forms: gel, cream, lotion.

Drug details

Generic Name
tretinoin
Brand Names
TRETINOIN, Tretinoin, Tretinoin (Microsphere), Tretinoin Cream, Altreno
Application Number
ANDA075589
Sponsor
Padagis US LLC
NDC Codes
40
Dosage Forms
GEL, CREAM, LOTION
Routes
TOPICAL
Active Ingredients
TRETINOIN

Indications and Usage

1 INDICATIONS AND USAGE Tretinoin capsules are indicated for the induction of remission in adults and pediatric patients 1 year of age and older with acute promyelocytic leukemia (APL) characterized by the presence of the t(15;17) translocation or PML/RARα gene expression, and who are refractory to or who have relapsed from anthracycline chemotherapy or for whom anthracycline-based chemotherapy is contraindicated. Tretinoin capsules are a retinoid indicated for induction of remission in adults and pediatric patients 1 year of age and older with acute promyelocytic leukemia (APL), characterized by presence of t(15;17) translocation or presence of PML/RARα gene expression, and who are refractory to or who have relapsed from anthracycline chemotherapy or for whom anthracycline-based chemotherapy is contraindicated.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.